Device
PROMUS Element™
PROMUS Element™ is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 33 (75.0%)
N/A1 (25.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
NCT02175706
completedphase_3
PROMUS Element Japan Small Vessel Trial
NCT01080261
completedphase_3
Optical Coherence Tomography for EVERolimus Eluting STent
NCT01146080
completedphase_3
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
NCT00824434
Clinical Trials (4)
Showing 4 of 4 trials
NCT02175706Not Applicable
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
NCT01080261Phase 3
PROMUS Element Japan Small Vessel Trial
NCT01146080Phase 3
Optical Coherence Tomography for EVERolimus Eluting STent
NCT00824434Phase 3
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4